Great news this morning for NOVA that should help push its momentum towards first resistance level in the next days and could definitely breakthrough if volume continues up from this news.
The U.S. Food and Drug Administration has approved Nova Mentis Life Science Corp.'s proprietary psilocybin drug orphan drug application to treat patients with fragile X...
NOVA announced today that they've just earned Psilocybin Orphan Drug Designation in Europe that once approved would give them ten years of market exclusivity. Positive news are accumulating for this small biopharma over the last 3 months and at some point investors will start accumulating again as it sits on a well supported floor at .08
I keep adding slowly at...
They keep dropping news every few days and they've been one of the few in this sector that had a positive trend over this past summer, so carefully optimistic if would break the up trend in the next week, but will wait to see a clear breakout signal with increasing daily volume. Do you DD!
Some nice volume movement yesterday (3x above average) for a +50% price increase and expecting this could quickly reach its first resistance level at .13 (for another +100% gain) in the coming days if volume continues above average and MACD trend reversal is confirmed. This is a small growth-oriented technology and services company supporting canabis business in...
Keeping a close eye on CYBIN as it's been progressing nicely since March while the entire market has been pressured down. Will watch for a bounce on the lower trend with increasing volume and MACD reversal before adding more to my position (current position average of 1.36).
I'm watching closely Nova Mentis this week as it seems to be sitting on a nice support floor at .09 with potential MACD reversal in coming days for a swing trade to .15 (and will be watching the volume build up for possible breakout above that first resistance). I'm in this trade already at .11 average price and currently increasing my position slowly (Note: Do...
Will keep an eye on MACD this today & tomorrow to confirm the trend reversing but could take it to .19 quickly (first resistance level) and then .30 if it breaks that level with increasing volume. Nice % gain potential for a short term play.
SILO has one of the first patent-pending nasal spray making psilocybin easier to access, administer and ingest. They've signed last week a licensing agreement with Brasil and Colombia and expecting now that market penetration in LATAM to continue. This marks the Company’s first commercial transaction of its new-to-world intellectual property and I believe that...
MACD crossing confirmed and moving above it's upper trendline with a solid floor at .20 tested several times. Could move fast with some volume increase and I see it reaching the .35 levels quickly after moving past some possible resistance in the .26 range
Nova Mentis Life has been under the radar from the recent "mush-rush" discussions (they are also in the psilocybin health wellness businesses) but the chart is looking great with its bottom trendline and reversing MACD. With only 54M float this one will run fast as soon as volume will pick up so I've started to slowly accumulate and expecting to easily reach the...
Sharing this observation as, since Lobe Sciences (formerly GreenStar Biosciences) announced it undertook a rebrand in November 2020 to shift toward the psychedelic medicine sector, it started to follow the market space trend. Seems to be consolidating on a good support in the .12-.13 range with an slow uptrend since Nov announcement, but will be a little more...
